175 related articles for article (PubMed ID: 11179485)
21. p16 overexpression: a potential early indicator of transformation in ovarian carcinoma.
Shigemasa K; Hu C; West CM; Clarke J; Parham GP; Parmley TH; Korourian S; Baker VV; O'Brien TJ
J Soc Gynecol Investig; 1997; 4(2):95-102. PubMed ID: 9101469
[TBL] [Abstract][Full Text] [Related]
22. Status of the DPC4 tumor suppressor gene in sporadic colon adenocarcinoma of Croatian patients: identification of a novel somatic mutation.
Popović Hadzija M; Radosevic S; Kovacević D; Lukac J; Hadzija M; Spaventi R; Pavelić K; Kapitanović S
Mutat Res; 2004 Apr; 548(1-2):61-73. PubMed ID: 15063137
[TBL] [Abstract][Full Text] [Related]
23. Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas.
Gunduz M; Nagatsuka H; Demircan K; Gunduz E; Cengiz B; Ouchida M; Tsujigiwa H; Yamachika E; Fukushima K; Beder L; Hirohata S; Ninomiya Y; Nishizaki K; Shimizu K; Nagai N
Gene; 2005 Aug; 356():109-17. PubMed ID: 15935570
[TBL] [Abstract][Full Text] [Related]
24. Expression and sequence analysis of the p21(WAF1/CIP1) gene in renal cancers.
Papandreou CN; Bogenrieder T; Loganzo F; Albino AP; Nanus DM
Urology; 1997 Mar; 49(3):481-6. PubMed ID: 9123723
[TBL] [Abstract][Full Text] [Related]
25. TSG101 is not mutated in lung cancer but a shortened transcript is frequently expressed in small cell lung cancer.
Oh Y; Proctor ML; Fan YH; Su LK; Hong WK; Fong KM; Sekido YS; Gazdar AF; Minna JD; Mao L
Oncogene; 1998 Sep; 17(9):1141-8. PubMed ID: 9764824
[TBL] [Abstract][Full Text] [Related]
26. Molecular cloning and characterization of LCRG1 a novel gene localized to the tumor suppressor locus D17S800-D17S930.
Li Y; Chen Z
Cancer Lett; 2004 Jun; 209(1):75-85. PubMed ID: 15145523
[TBL] [Abstract][Full Text] [Related]
27. Mutations of the p53 gene are not detectable in human testicular tumors.
Fleischhacker M; Strohmeyer T; Imai Y; Slamon DJ; Koeffler HP
Mod Pathol; 1994 May; 7(4):435-9. PubMed ID: 8066072
[TBL] [Abstract][Full Text] [Related]
28. Infrequent mutations of the activating transcription factor-2 gene in human lung cancer, neuroblastoma and breast cancer.
Woo IS; Kohno T; Inoue K; Ishii S; Yokota J
Int J Oncol; 2002 Mar; 20(3):527-31. PubMed ID: 11836564
[TBL] [Abstract][Full Text] [Related]
29. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
[TBL] [Abstract][Full Text] [Related]
30. Identification of DMC1, a novel gene in the TOC region on 17q25.1 that shows loss of expression in multiple human cancers.
Harada H; Nagai H; Tsuneizumi M; Mikami I; Sugano S; Emi M
J Hum Genet; 2001; 46(2):90-5. PubMed ID: 11281419
[TBL] [Abstract][Full Text] [Related]
31. Androgen receptor gene mutations do not occur in ovarian cancer.
Engehausen DG; Tong XW; Oehler MK; Freund CT; Schrott KM; Kieback DG
Anticancer Res; 2000; 20(2A):815-9. PubMed ID: 10810359
[TBL] [Abstract][Full Text] [Related]
32. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
Dong-Dong L; Xi-Ran Z
Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
[TBL] [Abstract][Full Text] [Related]
33. p51/p63, a novel p53 homologue, potentiates p53 activity and is a human cancer gene therapy candidate.
Kunisaki R; Ikawa S; Maeda T; Nakazaki Y; Kurita R; Harata M; Shutoh Y; Bai YS; Soda Y; Tanabe T; Dohi T; Kato R; Ikawa Y; Asano S; Tani K
J Gene Med; 2006 Sep; 8(9):1121-30. PubMed ID: 16832836
[TBL] [Abstract][Full Text] [Related]
34. Sequence variants of DLC1 in colorectal and ovarian tumours.
Wilson PJ; McGlinn E; Marsh A; Evans T; Arnold J; Wright K; Biden K; Young J; Wainwright B; Wicking C; Chenevix-Trench G
Hum Mutat; 2000; 15(2):156-65. PubMed ID: 10649492
[TBL] [Abstract][Full Text] [Related]
35. Role of TSG101 in uterine cervix cancer.
O'Boyle JD; Proctor ML; Fong KM; Lin WM; Miller DS; Muller CY
Gynecol Oncol; 1999 Dec; 75(3):401-5. PubMed ID: 10600297
[TBL] [Abstract][Full Text] [Related]
36. Reduced ING1b gene expression plays an important role in carcinogenesis of non-small cell lung cancer patients.
Kameyama K; Huang CL; Liu D; Masuya D; Nakashima T; Sumitomo S; Takami Y; Kinoshita M; Yokomise H
Clin Cancer Res; 2003 Oct; 9(13):4926-34. PubMed ID: 14581367
[TBL] [Abstract][Full Text] [Related]
37. p53 gene mutation analysis and antisense-mediated growth inhibition of human ovarian carcinoma cell lines.
Skilling JS; Squatrito RC; Connor JP; Niemann T; Buller RE
Gynecol Oncol; 1996 Jan; 60(1):72-80. PubMed ID: 8557231
[TBL] [Abstract][Full Text] [Related]
38. Frequent allelic losses and mutations of the p53 gene in human ovarian cancer.
Okamoto A; Sameshima Y; Yokoyama S; Terashima Y; Sugimura T; Terada M; Yokota J
Cancer Res; 1991 Oct; 51(19):5171-6. PubMed ID: 1680546
[TBL] [Abstract][Full Text] [Related]
39. Loss of expression of the p16 tumor suppressor gene is more frequent in advanced ovarian cancers lacking p53 mutations.
Havrilesky LJ; Alvarez AA; Whitaker RS; Marks JR; Berchuck A
Gynecol Oncol; 2001 Dec; 83(3):491-500. PubMed ID: 11733961
[TBL] [Abstract][Full Text] [Related]
40. [Study on mRNA expression of the human novel gene NM23-H1B in ovarian tumor].
Li W; Liu Y; Jin ZJ; Feng YJ; Huang LM; Chen J
Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):48-51. PubMed ID: 16635329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]